Peter D. Kies

2023

In 2023, Peter D. Kies earned a total compensation of $1.2M as Chief Financial Officer at Inovio Pharmaceuticals, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$172,314
Option Awards$218,593
Salary$622,881
Stock Awards$132,252
Other$15,000
Total$1,161,040

Kies received $622.9K in salary, accounting for 54% of the total pay in 2023.

Kies also received $172.3K in non-equity incentive plan, $218.6K in option awards, $132.3K in stock awards and $15K in other compensation.

Rankings

In 2023, Peter D. Kies' compensation ranked 1,018th out of 2,785 executives tracked by ExecPay. In other words, Kies earned more than 63.4% of executives.

ClassificationRankingPercentile
All
1,018
out of 2,785
63rd
Division
Manufacturing
610
out of 1,525
60th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
71
out of 230
69th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
44
out of 165
73rd
Industry
Surgical and Medical Instruments and Apparatus
39
out of 125
69th
Source: SEC filing on April 11, 2024.

Kies' colleagues

We found two more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2023.

2023

Jacqueline Shea

Inovio Pharmaceuticals

Chief Executive Officer

2023

Laurent Humeau

Inovio Pharmaceuticals

Chief Scientific Officer

News

You may also like